Medullary thyroid carcinoma (MTC) requires pre-treatment assessment through serum calcitonin determination, carcinoembryonic antigen determination, genetic testing and other diagnostic criteria before the start of treatment. This evidence concerns the gene CALCA and medullary thyroid gland carcinoma.